Xinhua News Agency, Shenzhen, April 24th (Reporter Zhao Ruixi) "China has completed the research and development of the new crown vaccine with all the strength of the whole country". "It is not only a leader in speed, but also in quality, and it is at the forefront of the world."
Yang Xiaoming, Chairman of Sinopharm China Biotechnology Co., Ltd., said at the "Shenzhen Forum" of the 19th China International Talent Exchange Conference held on the 24th.
Yang Xiaoming said that the vaccine industry, as a part of the biomedical industry, is an industry that must rely on technological innovation to develop continuously.
China's vaccine innovation has gone through a process from "following" to "paralleling" and then "leading".
Vaccine innovation is a long and difficult process. There are three core problems in the development of innovative vaccines: long time, high investment, and low success rate.
In the face of the new crown pneumonia epidemic, China has made a national effort to quickly develop an inactivated new crown vaccine in just 98 days, "not only leading in speed, but also in quality, and walking in the forefront of the world."
At present, there are 10 new crown vaccines in China that have entered phase III clinical trials. Not only are there a large number, but also the technical route is relatively complete and the progress is fast.
In addition, of the 11 vaccines that have been approved for emergency use worldwide, 5 are Chinese vaccines, reflecting China's leading position in the development of new crown vaccines.
He said that China's new crown inactivated vaccine not only goes fast, the product is safe and effective, and the supply is large.
The Sinopharm China Bio-New Crown Inactivated Vaccine has been approved for marketing in 5 countries and approved for use in 62 countries.
Yang Xiaoming said that in recent years, with the improvement of technology, the innovation of vaccine varieties in China has accelerated. In addition to the new crown inactivated vaccine, recombinant hepatitis E vaccine, hand-foot-mouth disease (EV71) vaccine, and Ebola vaccine are also my country's original vaccines.
The global vaccine varieties cover about 41 kinds of infectious diseases. China can produce vaccines against 36 kinds of diseases on its own. It is one of the few countries in the world that can rely on its own ability to solve immunization supply and vaccination.